Paul Tudor Jones Medical Devices

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$147B	$69.9 Million 0.16% of portfolio	650,620	Q2 2025 Added 154.02%
TMDX Trans Medics Group, Inc.	$4.17B	$16.6 Million 0.04% of portfolio	123,716	Q2 2025 Added 18.02%
PEN Penumbra Inc	$9.42B	$14.9 Million 0.03% of portfolio	58,189	Q2 2025 New
ITGR Integer Holdings Corp	$3.56B	$7.13 Million 0.02% of portfolio	57,971	Q2 2025 New
GMED Globus Medical Inc	$4.73B	$5.9 Million 0.01% of portfolio	100,000	Q2 2025 Added 11.11%
TNDM Tandem Diabetes Care Inc	$713M	$5.81 Million 0.01% of portfolio	311,517	Q2 2025 Reduced 23.14%
STE Steris PLC	$24.4B	$4.91 Million 0.01% of portfolio	20,435	Q2 2025 New
SIBN Si Bone, Inc.	$521M	$4.82 Million 0.01% of portfolio	256,064	Q2 2025 Added 1,386.67%
AORT Artivion, Inc.	$1.74B	$3.34 Million 0.01% of portfolio	107,409	Q2 2025 Reduced 54.29%
LNSR Lensar, Inc.	$142M	$3.12 Million 0.01% of portfolio	236,710	Q2 2025 Reduced 14.55%
PODD Insulet Corp	$21.5B	$2.84 Million 0.01% of portfolio	9,038	Q2 2025 New
DCTH Delcath Systems, Inc.	$93.5M	$2.69 Million 0.01% of portfolio	197,749	Q2 2025 New
BFLY Butterfly Network, Inc.	$241M	$2.28 Million 0.01% of portfolio	1,138,518	Q2 2025 Reduced 21.87%
CNMD Conmed Corp	$1.65B	$2.16 Million 0.0% of portfolio	41,526	Q2 2025 New
TMCI Treace Medical Concepts, Inc.	$362M	$2 Million 0.0% of portfolio	339,334	Q2 2025 Reduced 1.21%
ATEC Alphatec Holdings, Inc.	$1.65B	$1.41 Million 0.0% of portfolio	127,124	Q2 2025 Reduced 69.56%
NPCE Neuro Pace Inc	$227M	$1.32 Million 0.0% of portfolio	118,891	Q2 2025 Added 147.64%
KIDS Orthopediatrics Corp	$449M	$1.12 Million 0.0% of portfolio	51,931	Q2 2025 New
INGN Inogen Inc	$173M	$915,000 0.0% of portfolio	130,235	Q2 2025 Reduced 19.2%
CVRX Cv Rx, Inc.	$155M	$903,000 0.0% of portfolio	153,596	Q2 2025 Added 30.14%
RXST Rx Sight, Inc.	$203M	$666,000 0.0% of portfolio	51,262	Q2 2025 Reduced 41.28%
OFIX Orthofix Medical Inc.	$276M	$656,000 0.0% of portfolio	58,847	Q2 2025 Reduced 67.41%
LUNG Pulmonx Corp	$59.3M	$624,000 0.0% of portfolio	241,051	Q2 2025 Added 17.69%
BVS Bioventus Inc.	$451M	$600,000 0.0% of portfolio	90,641	Q2 2025 Reduced 62.45%
MDT Medtronic PLC	$122B	$538,000 0.0% of portfolio	6,177	Q2 2025 Reduced 65.75%
CLPT Clear Point Neuro, Inc.	$258M	$290,000 0.0% of portfolio	24,317	Q2 2025 Reduced 81.11%
ARAY Accuray Inc	$138M	$289,000 0.0% of portfolio	211,597	Q1 2025 Added 95.27%
AVNS Avanos Medical, Inc.	$502M	$144,000 0.0% of portfolio	11,794	Q2 2025 Reduced 75.57%
SENS Senseonics Holdings, Inc.	$219M	$83,000 0.0% of portfolio	174,383	Q4 2022 Reduced 3.82%

Shares Options

Paul Tudor Jones

Paul Tudor Jones is the founder and CEO of Tudor Investment Corp, a successful investment firm that focuses on macro investing. Jones is known for his expertise in macro investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Paul Tudor Jones's portfolio

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account